Curated Content for EPs: Conduction System Pacing

This bundle provides access to 5 sessions and 3 ACE credits. 

Sessions from HRS2023 included in this bundle:

• 453690 - Heart Rhythm Presents: New Advances in Conduction System Pacing and the Risk Stratification of Cardiac Arrhythmias
• 439242 - ECG in Conduction System Pacing: An Essential Tool for Success?
• 439271 - How to Choose the Type Conduction System Pacing
• 451355 - Difficult Implants in the Conduction System: Tips and Tricks from the Experts
• 452766 - What is New in Conduction System Pacing?

Nicoline van den Berg, MD, PhD | Amsterdam UMC

• Temporary Consultancy for Contract Research: Julius Research, BV

Mihail Chelu, MD, PhD, FHRS | Baylor College of Medicine

• Contracted Grants for Named Research: Abbott
• Research: Impulse Dynamics, USA
• Speaking and Teaching: Impulse Dynamics, USA

Juan Diaz, MD | Clinica Las Vegas

• Bayer Healthcare Pharmaceuticals, Pfizer, Inc, AstraZeneca, Boston Scientific, Medtronic

Aanand Ganesan, MBBS, CEPS-A | Flinders University

• Nothing relevant to disclose.

Tonya Glotzer, MD, FHRS | Electrophysiology Associates

• Speaking and Teaching: Abbott, Medtronic

Michael Gold, MD, PhD, FHRS | MUSC

• Speaking and Teaching: CVRx, Medtronic, Boston Scientific

Bengt Herweg, MD, FHRS | University of South Florida Morsani College of Medicine

• Speaking and Teaching: Abbott, Medtronic

Weijian Huang, MD, FHRS | First Hospital Affiliated to WZMU

• Nothing relevant to disclose.

Marek Jastrzebski, MD | SP ZOZ Szpital Uniwersytecki

• Nothing relevant to disclose.

Juhani Junttila, MD, PhD | University of Oulu

• Speaking and Teaching: Boehringer Ingelheim, BMS/Pfizer Alliance
• Membership on Advisory Boards: Boehringer Ingelheim, BMS/Pfizer Alliance, Bayer Healthcare Pharmaceuticals

Valentina Kutyifa, MD, PhD, FHRS, FACC, FESC | University of Rochester Medical Center

• Speaking and Teaching: Medtronic
• Research: Spire, Inc., Boston Scientific, Zoll Medical, Biotronik, NIH/NHILBI, Abbott

Shunmuga Sundaram Ponnusamy MBBS, MD, CEPS-A, | Velammal Medical College Hospital and Research Institute

• Speaking and Teaching: Medtronic

John Rickard MBA, MD, MPH

• Contracted Grants for Named Investigators: St. Jude Medical Center
• Speaking and Teaching: Medtronic, St. Jude Medical Center, Boston Scientific

Parikshit S. Sharma, MD, MPH, FHRS | Rush University

• Speaking and Teaching: Biotronik, Medtronic, Abbott

Pablo Morina Vazquez, MD | Hospital General Juan Ramon Jiminez

• Advisory Board: Abbott, Medtronic

Zachary Whinnett, BMBS | Imperial College London

• Research: Medtronic
• Advisory Board: Abbott, Boston Scientific, Medtronic

Francesco Zanon, MD, FHRS | Santa Maria Della Misericordia Hospital 

• Speaking and Teaching: Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort

Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.

ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
• Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

All relevant financial relationships have been mitigated.